tiprankstipranks
Trending News
More News >
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market

SynAct Pharma AB (SYNACT) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting SynAct Pharma AB is a Buy.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 22.21, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 21.94, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.

SynAct Pharma AB (SYNACT) Pivot Points

Feb 02, 2026, 09:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.63
21.17
21.43
21.97
22.23
22.77
23.03
Fibonacci
21.17
21.47
21.66
21.97
22.27
22.46
22.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Feb 02, 2026, 09:22 AM
Period
Simple
Exponential
MA5
21.93Sell
21.71Sell
MA10
22.19Sell
22.08Sell
MA20
22.48Sell
22.21Sell
MA50
21.67Sell
21.94Sell
MA100
21.66Sell
21.42Sell
MA200
20.31Buy
20.11Buy
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 22.08, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 21.42, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 21.67, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 21.66, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 20.31, creating a Buy signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Feb 02, 2026, 09:22 AM
Name
Value
Implied Action
RSI (14)
39.28
Neutral
STOCH (9,6)
11.85
Buy
STOCHRSI (14)
14.01
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
12.68
Buy
Williams %R
-96.05
Buy
CCI (14)
-149.64
Buy
ATR (14)
0.99
-
Ultimate Oscillator
42.98
Neutral
ROC
-8.79
Sell
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 39.28, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 12.68, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is -149.64, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is -8.79, creating a Sell signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Sell.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 39.28, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is -0.02, which suggests SYNACT is a Buy.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 21.93, which suggests SYNACT is a Sell.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 22.48, which suggests SYNACT is a Sell.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 21.67, which suggests SYNACT is a Sell.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 20.31, which suggests SYNACT is a Buy.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -96.05, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is -149.64, which suggests SYNACT is a Buy.
                    What is the share price of SynAct Pharma AB?